OFFICIAL PUBLICATION OF

by its subsidiary APPco

New once-daily Hep C treatment recommended for PBS

Megan Haggan 23/01/2017

liver cancer: "liver" spelled out on post-its hanging from line

The first and only one-tablet, once-a-day treatment for all genotypes of chronic hepatitis C infection has been recommended for PBS listing Gilead Sciences Australia has announced that the TGA has registered a new treatment for the treatment of chronic hepatitis C infection in adults. The PBAC has also recommended EPCLUSA (sofosbuvir/velpatasvir) for listing on the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

What does the future look like for CWH/Sigma shareholders?

Yeh but CWH's entire business model is to go to areas with low rent and charge below cost prescriptions and…

Bob Tran

What does the future look like for CWH/Sigma shareholders?

if they can't grow internally they can easily acquire other store and distribution centre and shareholder would be more than…

viknesh bramasta

What does the future look like for CWH/Sigma shareholders?

Ponraj unlike Coles CWH sell medications LOL - if they can't grow internally they can easily acquire other store and…

viknesh bramasta

What does the future look like for CWH/Sigma shareholders?

Undervalued. With the data Sigma have on your purchasing (even if not primary supplier), combined with what they receive from…

Justin Levine

New once-daily Hep C treatment recommended for PBS

Previous APP2017 welcomes back Malcolm Scrymgeour

Next The reason behind skyrocketing autism rates

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous APP2017 welcomes back Malcolm Scrymgeour

Next The reason behind skyrocketing autism rates

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.